In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of Bicara Therapeutics Inc (NASDAQ: BCAX) closed at $12.98 in the last session, down -0.15% from day before closing price of $13.00. In other words, the price has decreased by -$0.15 from its previous closing price. On the day, 0.74 million shares were traded.
Ratios:
We take a closer look at BCAX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 36.01 and its Current Ratio is at 36.01. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wedbush on February 06, 2025, initiated with a Outperform rating and assigned the stock a target price of $31.
On December 06, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $42.
On November 05, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $48.Rodman & Renshaw initiated its Buy rating on November 05, 2024, with a $48 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 16 ’24 when RA CAPITAL MANAGEMENT, L.P. bought 1,833,000 shares for $18.00 per share. The transaction valued at 32,994,000 led to the insider holds 4,303,418 shares of the business.
Flynn James E bought 70,000 shares of BCAX for $1,260,000 on Sep 17 ’24. The Possible Members of 10% Group now owns 897,587 shares after completing the transaction at $18.00 per share.
Stock Price History:
Over the past 52 weeks, BCAX has reached a high of $28.09, while it has fallen to a 52-week low of $11.10. The 50-Day Moving Average of the stock is -11.12%, while the 200-Day Moving Average is calculated to be -31.31%.
Shares Statistics:
A total of 54.41M shares are outstanding, with a floating share count of 30.89M. Insiders hold about 43.23% of the company’s shares, while institutions hold 55.58% stake in the company.
